The E3 ubiquitin ligase Pellino 1 can be interconverted between inactive and active forms by a reversible phosphorylation mechanism. 
INTRODUCTION
Pellino was originally discovered in the Toll signalling pathway of Drosophila melanogaster as a protein that interacts with Pelle, the orthogue of IRAK {IL-1R [IL (interleukin)-1-receptor]-associated kinase} in the fly [1] . Three isoforms of Pellino were later identified in mammalian cells, termed Pellino 1, 2 and 3, and shown to interact with IRAK1 and IRAK4 in cotransfection studies [2, 3] . We, and others, then showed that the Pellino isoforms are E3 ubiquitin ligases that become competent to catalyse the formation of polyubiquitin chains only when they have been phosphorylated by IRAK1 or IRAK4 in vitro [3] [4] [5] [6] . However, whether IRAK1, IRAK4 or both of these protein kinases are involved in activating the mammalian Pellino isoforms in vivo is unknown.
Progress in understanding the regulation and function of Pellino isoforms has been hampered by a lack of antibodies capable of recognizing and immmunoprecipitating the endogenous proteins. However, we recently generated a Pellino 1-specific antibody and exploited it to show that the level of expression of endogenous Pellino 1 is greatly increased when macrophages are stimulated with the TLR (Toll-like receptor) 4 ligand LPS (lipopolysaccharide) or the TLR3 ligand poly(I:C) [7] . Surprisingly, these agonists were found to stimulate the expression of Pellino 1 mRNA and protein by a signalling pathway dependent on the adaptor protein TRIF [TIR (Toll/IL-1 receptor) domain-containing adaptor protein inducing interferon β], but independent of the MyD88 (myeloid differentiation primary response gene 88)-dependent signalling pathway in which IRAK1 and IRAK4 participate. Further analysis revealed that the TRIF-dependent induction of Pellino 1 mRNA (HUGO Gene Nomenclature Committee name PELI1) was mediated by the transcription factor IRF3 (interferon regulatory factor 3), which is activated in this pathway by the IKK {IκB [inhibitor of NF-κB (nuclear factor κB)] kinase}-related kinases IKKε and TBK1 (TANK {TRAF [TNF (tumour-necrosis-factor)-receptorassociated factor]-associated NF-κB activator}-binding kinase 1). Moreover, we found that the IKK-related kinases also catalysed the phosphorylation and activation of the endogenous Pellino 1 in LPS-or poly(I:C)-stimulated macrophages [7] .
These findings raised the further question of whether other TLR ligands and inflammatory stimuli activate Pellino 1 via the IKKrelated kinases, or whether they activate Pellino 1 via one or more members of the IRAK family or additional protein kinases. In the present paper, we establish that IRAK1 is the major protein kinase that catalyses the activation of Pellino 1 in IL-1-stimulated MEFs (mouse embryonic fibroblasts) and that, surprisingly, it is the IKK-related kinases, and not the IRAKs, which activate Pellino 1
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when macrophages are stimulated with TLR ligands that signal via MyD88. We further demonstrate that the IKK-related kinases also mediate the activation of Pellino 1 by TNFα.
EXPERIMENTAL

Materials
The TAK1 [TGF (transforming growth factor)-β-activated kinase 1] inhibitor 5Z-7-oxozeanol [8] was purchased from Bioaustralis Fine Chemicals and staurosporine was from LC Laboratories, whereas the TBK1/IKKε inhibitor MRT67307 [9] was synthesized by Dr Natalia Shpiro (MRC Protein Phosphorylation Unit, University of Dundee, Dundee, Scotland, U.K.). The JNK (c-Jun N-terminal kinase) inhibitor JNK-IN-8 and the JNK/IRAK1 inhibitor JNK-IN-7 were synthesized as described previously [10] and were provided by Nathanael Gray and Tinghu Zhang (Harvard Medical School, Boston, MA, U.S.A.). Compounds were dissolved and stored at − 20 • C as 10 mM solutions in DMSO. Mouse IL-1α and mouse TNFα were purchased from Sigma and used to stimulate MEFs. Human IL-1β was expressed and purified as described previously [11] and used to stimulate human IL-1R cells. FLAG-tagged ubiquitin was from Boston Chemicals, whereas the TLR1/2 ligands Pam 3 CSK 4 and R837 were from Invivogen. UBE1 (ubiquitin-like modifier activating enzyme 1) and the Ubc13 (E2 ubiquitin-conjugating enzyme 13)-Uev1a (ubiquitin conjugating enzyme variant 1a) complex, used for the assay of Pellino 1, were expressed and purified by the Protein Production and Assay Development team of the Protein Ubiquitylation Unit at Dundee (http://scills.ac.uk) co-ordinated by Dr Axel Knebel.
Antibodies
Anti-FLAG and anti-(α-tubulin) antibodies were purchased from Sigma, and antibodies that recognize p105/NFκB1 phosphorylated at Ser 933 , p38α MAPK (mitogen-activated protein kinase) phosphorylated at Thr  180 and Tyr  182 , JNKs phosphorylated  at Thr  183 and Tyr  185 , TBK1 phosphorylated at Thr  172 , and further antibodies that recognize TBK1 and IKKε were from Cell Signalling Technology. Anti-TAK1 and anti-IRAK1 antibodies were purchased from Santa Cruz Biotechnology. Characterization of the anti-(Pellino 1) antibody has been described previously [7] .
Generation of IRAK1[D358A] mice
To generate mice in which wild-type IRAK1 was replaced by a catalytically inactive mutant, Asp 358 in the DGF motif was mutated to alanine. Asp 358 is encoded in exon 9 of the mouse Irak1 gene, and a targeting vector was constructed to introduce the required mutation. The vector consisted of a 5 arm of homology followed by a loxP site, then a pCMV-puro-pA marker that was flanked by F3 sites (a mutant form of frt). This was followed by the genomic sequence that contained exon 9 (with the D358A mutation) and exon 10 of the Irak1 gene, then an frt-flanked neomycin-selectable marker, another loxP site, the 3 arm of homology and finally a thymidine kinase cassette to allow negative selection (Figure 1 ). The neomycin marker consisted of a pGK promoter, the neomycin-resistance gene open reading frame, an IRES (internal ribosome entry site) sequence, an in-frame start codon and the splice donor site from exon 10 of IRAK1. This selection cassette acts as a polyA trap and also allows an RT (reverse transcription)-based RNA screen for homologous recombination. The three arms of homology to the IRAK1 locus were generated by PCR for an appropriate murine The mouse IRAK1 locus consists of 14 exons, with Asp 358 encoded in exon 9. A potential exon that may give rise to splicing isoforms exists between exons 11 and 12 (white rectangle). The targeting vector used to generate the knockin, consisting of arms of homology to IRAK1 as well as thymidine kinase (TK), puromycin (puro-pA) and polyA trap neomycin (neo-IRES) selectable markers, is shown. The positions of the loxP (white triangles), F3 (grey triangles) and frt (black triangles) recombinase sites are indicated. ES cells were targeted with this vector and PCR-screened by analysis of genomic DNA for incorporation of the puromycin and neomycin markers using the primers P1-P3 and N1-N3 respectively. Homologous recombination was confirmed using an RT-PCR screen using the primers R1 and R2. Once knockin mice were generated using the targeted ES cells, the selectable markers were removed by crossing to Flp transgenic mice.
BAC clone using the primers listed in Supplementary Figure  S1 (at http://www.BiochemJ.org/bj/441/bj4410339add.htm). All PCR products were fully sequenced to ensure the absence of PCR-generated mutations.
The targeting vector was used to generate mutant ES (embryonic stem) cells as described previously [12] . Briefly, the vector was electroporated into E14 (E is embryonic day) Sv129J ES cells. ES cells were then grown under positive selection with puromycin and G418, and negative selection with ganciclovir. Resistant colonies were picked, expanded and screened for the presence of the knockin mutation at the IRAK1 locus. To ensure incorporation of the puromycin-and neomycin-selectable markers, a PCR of genomic DNA was used (Figure 1 ). To screen for homologous recombination at the IRAK1 locus, total RNA was isolated and screened by RT-PCR, using a primer in the IRES sequence and a primer in an IRAK1 exon 3 to the targeting vector ( Figure 1 ). This PCR resulted in a 710 bp product, whose identity was confirmed by sequencing. Primer sequences are shown in Supplementary Figure S1 .
Positive ES cells were used to generate chimaeric mice as described previously [12] . Chimaeric mice giving germ-line transmission were bred to C57/Bl6 Flp transgenic mice to excise the two selectable markers, whose deletion was confirmed by PCR screening (Figure 1 ). Routine genotyping of the mice was carried out using the same primers. All mice were maintained under specific pathogen-free conditions and housed in accordance with United Kingdom and European Union law. Work was carried out under a United Kingdom Home Office license and was subject to and approved by local ethical review.
Cell culture
MEFs from the IRAK1[D358A] mice, Pellino 1[F397A] mice and wild-type control mice were isolated at embryonic developmental stage E12/13 and cultured in DMEM (Dulbecco's modified Eagle's medium) containing heat-inactivated 10 % (v/v) FBS (foetal bovine serum), 1 % (v/v) penicillin/streptomycin solution, 2 mM L-glutamine, 1 mM sodium pyruvate, 0.1 mM nonessential amino acids and 0.05 mM 2-mercaptoethanol. For immortalization, primary MEFs that had been passaged seven to eight times were further passaged one into two when reaching 90 % confluency, until the cells started to grow again at a normal rate. Immortalized MEFs from mice expressing a truncated inactive form of TAK1 [13] , and from double-knockout mice that do not express TBK1 and IKKε, were produced as described previously [14] . All immortalized cell lines were cultured at 37
• C in DMEM containing 10 % FBS and antibiotics (100 units/ml penicillin and 100 μg/ml streptomycin) in a humidified atmosphere containing 5 % CO 2 . Primary BMDMs (bone-marrow-derived macrophages) were generated from the bone marrow of mice as described previously [7] , except that they were cultured in DMEM containing 20 % L929-preconditioned medium, 10 % heat-inactivated FBS, antibiotics (100 units/ml penicillin and 100 μg/ml streptomycin), 1 mM sodium pyruvate, 0.2 mM 2-mercaptoethanol and non-essential amino acids at the concentrations recommended by the manufacturer (Gibco). The transformed macrophage cell line RAW264.7 was obtained from the A.T.C.C., whereas HEK (human embryonic kidney)-293 cells stably expressing the IL-1R, termed IL-1R cells, and IRAK1-null IL-1R cells were kindly provided by Xiaoxia Li and George Stark (Cleveland Clinic Foundation, Cleveland, OH, U.S.A.).
Cell stimulation, cell lysis and immunoblotting
Pharmacological inhibitors dissolved in DMSO or an equal volume of DMSO for control incubations were added to the culture medium of cells grown as monolayers, incubated for 1 h and then stimulated with 10 ng/ml IL-1β, 5 ng/ml IL-1α, 10 ng/ml TNFα or 1 μg/ml Pam 3 CSK 4 for the times indicated in the Figure legends. All incubations were carried out at 37
• C in a humidified atmosphere containing 5 % CO 2 . Thereafter, cells were washed in ice-cold PBS, extracted in lysis buffer [50 mM Tris/HCl (pH 7.4), 1 mM EDTA, 1 mM EGTA, 50 mM sodium fluoride, 5 mM sodium pyrophosphate, 1 mM sodium orthovanadate, 10 mM sodium 2-glycerophosphate, 0.27 M sucrose, 1 % (v/v) Triton X-100, 1 mM dithiothreitol, 1 mM PMSF and 1 mM benzamidine], centrifuged for 15 min at 13 000 g at 4
• C and the supernatant, termed the cell extract, was removed. Protein concentrations in the cell extracts were determined using the Bradford [14a] procedure. For immunoblotting, cell extracts (20 μg of protein) were separated by SDS/PAGE, transferred on to PVDF membranes and immunoblotted using the ECL (enhanced chemiluminescence) system (GE Healthcare).
Immunoprecipitation of Pellino 1 and assay of its E3 ligase activity
Cell extract protein (2 mg) was incubated for 16 h at 4
• C with 1 μg of anti-(Pellino 1) antibody attached to Protein G-Sepharose (7.5 μl packed beads) on a rotating wheel. The beads were collected by brief centrifugation (2 min at 780 g at 4
• C), washed three times with 0.5 ml of 50 mM Tris/HCl (pH 7.5), 1 % (v/v) Triton X-100, 0.05 % 2-mercaptoethanol and 0.2 M NaCl, and once with 50 mM Tris/HCl (pH 7.5) and 5 mM MgCl 2 .
The supernatant from the last wash was removed and the immunoprecipitated Pellino 1 was resuspended in 20 μl of 50 mM Tris/HCl (pH 7.5), 5 mM MgCl 2 , 0.1 μM UBE1, 0.05 μM Ubc13-Uev1a, 0.05 mM FLAG-ubiquitin and 2 mM ATP, and in the presence of the non-specific protein kinase inhibitor staurosporine (75 μM) to prevent any phosphorylation and activation of Pellino 1 during the assay by protein kinases present
Figure 2 Evidence that IRAK1 catalyses the activation of endogenous Pellino 1 in IL-1R cells (A) IRAK1-null IL-1R cells (IRAK1
− / − , lanes 1-5) and IL-1R cells (IRAK1 + / + , lanes 6-10) were stimulated with 10 ng/ml human IL-1β for the times indicated. Pellino 1 was immunoprecipitated from the cell extracts and its ability to form unanchored polyubiquitin chains was measured in a ubiquitylation assay using FLAG-ubiquitin as described in the Experimental section. The reactions were terminated by denaturation in SDS, and after SDS/PAGE and transfer on to PVDF membranes, the gels were immunoblotted with an anti-FLAG antibody to detect the polyubiquitin chains formed (top panel). Aliquots of the cell extracts were also subjected to SDS/PAGE followed by immunoblotting with the antibodies indicated (bottom four panels). (B) IL-1R cells were incubated for 1 h without ( − ) or with ( + ) 2 μM MRT67307 or 1 μM 5Z-7-oxozeanol, or both compounds, before stimulation for 15 min without ( − ) or with ( + ) 10 ng/ml IL-1β. The cells were lysed and the E3 ubiquitin ligase activity of Pellino 1 was measured as described in (A). Cell extracts were immunoblotted as described in (A). All of the experiments described in this Figure were performed at least three times with similar results. p-, phospho.
in the immunoprecipitates as trace contaminants. The reactions were incubated for 60 min at 30
• C and terminated by denaturation in SDS. Following SDS/PAGE to separate the unanchored Lys 63 -polyubiquitin chains formed in this assay and transfer on to PVDF membranes, immunoblotting was carried out using an anti-FLAG antibody to detect the formation of the polyubiquitin chains.
RESULTS
IRAK1 is required for the IL-1-stimulated activation of Pellino 1 in human IL-1R cells
We initially studied whether endogenous Pellino 1 could be activated by IL-1β in human IL-1R cells. IL-1β stimulated a rapid conversion of Pellino 1 from an inactive into an active E3 ubiquitin ligase in these cells, which was maximal within 10 min and sustained for at least 1 h. In contrast, IL-1β was unable to activate Pellino 1 in IRAK1-null IL-1R cells (Figure 2A) . In IRAK1-null IL-1R cells, stimulation with IL-1β did not induce any activation of the canonical IKKs (IKKα or IKKβ), as judged by the lack of phosphorylation of their substrate p105/NFκB1 ( Figure 2A ), or the activation of p38 MAPK and JNK [15] , making it impossible to decide whether the activation of Pellino 1 had been catalysed directly by IRAK1 or by another protein kinase whose activation was dependent on the presence of the IRAK1 protein. We therefore inhibited all of the protein kinases known to be activated 'downstream' of IRAK1 by incubating the cells with 5Z-7-oxozeaenol, an inhibitor of the protein kinase TAK1, which prevents the activation of its downstream targets, namely the canonical IKKs, IKKα and IKKβ, and the MAPK kinases that activate p38 MAPKs and JNKs [8] . We also carried out these experiments in the presence and absence of MRT67307, an inhibitor of the IKK-related kinases IKKε and TBK1, at concentrations that completely inhibit these enzymes in cells [9] . These studies showed that the IL-1β-stimulated activation of Pellino 1 was unimpaired in IL-1R cells incubated with 5Z-7-oxozeaenol plus MRT67307 ( Figure 2B) , consistent with the phosphorylation of Pellino 1 being catalysed directly by IRAK1.
The catalytic activity of IRAK1 is required for the IL-1-stimulated activation of Pellino 1 in MEFs
To investigate whether IRAK1 catalytic activity was required for the activation of Pellino 1, we generated mice that expressed the catalytically inactive IRAK1[D358A] mutant instead of the wildtype protein (Figure 1 ). These knockin mice were born at normal Mendelian frequencies, were of normal size and weight and did not spontaneously develop any obvious phenotype. The IRAK1[D358A] mutant was expressed at a lower level than the wild-type protein in MEFs or BMDMs, as indicated in some of the Figures presented later in the paper. The IL-1α-stimulated increase in the phosphorylation of the IKKβ substrate p105/NFκB1 or the phosphorylation (activation) of p38 MAPK and JNKs was equally strong and slightly more prolonged in immortalized MEFs from IRAK1[D358A] mice as compared with MEFs from wild-type mice, but the activation of Pellino 1 was greatly reduced ( Figure 3A) . The IL-1α-stimulated activation of Pellino 1 was reversed by treatment with a protein phosphatase ( Figure 3B ), showing that activation had been triggered by a phosphorylation event.
We have generated mice in which wild-type Pellino 1 is replaced by the E3-ligase inactive mutant Pellino 1[F397A] (K. Enesa, J.S.C. Arthur and P. Cohen, unpublished work). This mutant is less stable than wild-type Pellino 1 in vivo, explaining why it is expressed at much lower levels than wild-type Pellino 1 in cells. We found that Pellino 1 immunoprecipitated from MEFs expressing the Pellino 1[F397A] mutant had no E3 ligase activity (Supplementary Figure S2A at http://www. BiochemJ.org/bj/441/bj4410339add.htm). Similarly, no E3 ligase activity could be detected if the Pellino 1 antibody was replaced by a control IgG (Supplementary Figure S2B) . These studies indicated that the E3 ligase activity being measured after immunoprecipitation of Pellino 1 was indeed catalysed by Pellino 1 and not by another E3 ligase present in the immunoprecipitates as a contaminant.
Interestingly, Pellino 1 was consistently expressed at a significantly higher level in immortalized MEFs from the (A and B) were also subjected to SDS/PAGE and immunoblotted with the antibodies indicated. Similar results were obtained in two independent experiments. p-, phospho.
IRAK1
[D358A] mice than in MEFs from wild-type mice ( Figure 3A) , and was also present at higher levels in the IRAK1-null IL-1R cells than in IL-1R cells (Figure 2A ). These observations suggest that IRAK1 catalytic activity may control the level of expression of Pellino 1 protein in these cells.
We next studied the activation of Pellino 1 by IL-1α in immortalized MEFs expressing a truncated inactive form of TAK1. IL-1α stimulation did not activate the canonical IKKs and MAPKs in these MEFs as expected [13] , but still induced a robust activation of Pellino 1 ( Figure 3C ). The IKK-related kinases are still activated by IL-1α in TAK1-deficient MEFs [9] , but the further addition of MRT67307 to these cells at concentrations that obliterate IKKε and TBK1 activity [9] had no effect on the IL-1α-stimulated activation of Pellino 1 ( Figure 3C) . Similarly, the combined addition of the TAK1 inhibitor 5Z-7-oxozeaenol and the IKKε/TBK1 inhibitor MRT67307 also had no effect on the IL-1α-stimulated activation of Pellino 1 in wildtype MEFs (Supplementary Figure S3 at http://www.BiochemJ. org/bj/441/bj4410339add.htm). Moreover, the IL-1α-stimulated activation of Pellino 1 was similar in immortalized MEFs from wild-type mice and mice that do not express the IKK-related kinases ( Figure 3D ).
The IKK-related kinases mediate the activation of Pellino 1 by TLR ligands that signal via MyD88
We have shown previously that the IKK-related kinases (IKKε and TBK1) are the major protein kinases in the RAW264.7 macrophage cell line that mediate the activation of Pellino 1 by the TLR3 ligand poly(I:C), which signals via the adaptor TRIF and the TLR4 ligand LPS, which signals via both TRIF and the adaptor MyD88 [7] . To investigate which protein kinases activate Pellino 1 in response to TLR ligands that only signal via MyD88, we stimulated the RAW264. Figure 4D ).
Pharmacological inhibition of IRAK1
Two compounds, termed JNK-IN-8 and JNK-IN-7, have recently been developed and characterized [10] . These compounds are structurally very similar, but whereas the former is a specific covalent inhibitor of JNKs, the latter inhibits IRAK1 as well as JNK in vitro. Neither compound inhibits IRAK4 [10] . Consistent with these findings, both compounds suppressed the IL-1β-stimulated phosphorylation of c-Jun in IL-1R cells, an established substrate of the JNKs, but only JNK-IN-7 inhibited the To our knowledge, whether the pro-inflammatory cytokine TNFα stimulates the activation of a Pellino isoform has not been studied previously. It was therefore of interest to examine whether TNFα activated Pellino 1 in MEFs and, if so, which protein kinase mediated this effect, as TNFα does not signal via TRIF, MyD88 or the IRAKs, but instead via a distinct adaptor, termed TRADD (TNF-receptor-type-1-associated death domain protein). We found that TNFα stimulated a robust activation of Pellino 1, which could be observed after 10 min and was maximal between 20 and 30 min ( Figure 6A ). The TNFα-induced activation of Pellino 1 was abolished by the inclusion of MRT67307 in the cell culture medium ( Figure 6B ) and did not occur in MEFs that do not express the IKK-related kinases ( Figure 6C ).
DISCUSSION
In the present study, we have exploited pharmacological inhibitors and mouse cells deficient in particular protein kinases to define which of these enzymes activates Pellino 1 in the innate immune system. IRAK1 has been identified as the major protein kinase that mediates the activation of Pellino 1 by IL-1 in MEFs or human IL-1R cells, whereas the IKK-related kinases (IKKε and TBK1) are the major enzymes mediating the activation of Pellino 1 by TNFα in MEFs or by TLR-activating ligands in BMDMs, irrespective of whether the TLR ligand signals via MyD88, TRIF or both adaptors ( Figure 7 ) [7] . The IRAK1-catalysed activation of Pellino 1 in IL-1-stimulated MEFs provides the first direct read-out for IRAK1 catalytic activity in cells.
The finding that TLR ligands and IL-1, which both signal via MyD88, employ different protein kinases to activate Pellino 1 was surprising since these agonists all employ the IRAK isoforms to drive downstream signalling events. It would therefore be of considerable interest to know whether this is a cell-specific difference and, if not, how and why Pellino 1 selects different kinases for its activation by particular agonists in the same cell. The structure of the N-terminal portion of Pellino 2 has been elucidated and comprises an FHA (Forkhead-associated) domain and a region of anti-parallel β-sheet, termed the 'wing appendage', that loops out from the FHA domain [16] . This is followed by a C-terminal RING (really interesting new gene)-like domain [3] that carries the E3 ligase activity of Pellino 1. FHA domains are known to bind phosphothreonine residues in proteins [17] , and the active autophosphorylated form of IRAK1, and not a catalytically inactive mutant, was found to interact with Pellino isoforms in co-transfection/co-immunoprecipitation experiments [3] . This suggests that autophosphorylated IRAK1 may be recruited to the FHA domain, enabling it to phosphorylate the key activating sites, which are located on the 'wing appendage' and immediately N-terminal to the RING domain [6] . One or more phosphorylation sites on the IKK-related kinases may also lead to their recruitment to the FHA domain of Pellino 1. Stimulation of MEFs with TNFα induces the phosphorylation and activation of the IKK-related kinases [18] , but not IRAK1, which can explain why the IKK-related kinases activate Pellino 1 when MEFs are stimulated with this ligand. However, ligands that signal via MyD88 activate IRAK1 as well as the IKK-related kinases. In this situation, perhaps the different states of phosphorylation of IRAK1 and the IKK-related kinases and/or differences of the precise sites of phosphorylation in MEFs and macrophages may determine which protein kinase is recruited preferentially to the FHA domain of Pellino 1. Whether IRAK1, the IKKrelated kinases or additional protein kinases activate Pellino 2 and Pellino 3 in response to these or other agonists is unknown, and the generation of antibodies that selectively immunoprecipitate Pellino 2 or 3 from cell extracts will be needed to address this question.
It In Drosophila, Pellino has been shown to function in the production of the anti-bacterial peptide Drosomycin [19] , but the roles of Pellino isoforms in mammalian cells are unknown. We have begun to address this issue by generating knockin mice in which each of the wild-type Pellino isoforms have been replaced by E3 ligase inactive mutants. Consistent with our finding that Pellino 1 is activated and induced by the poly(I:C)-TLR3-TRIF-TBK1/IKKε-IRF3 signalling pathway in macrophages [7] , we have recently found that Pellino 1 functions to control the transcription of the interferon β gene and hence interferon β secretion by this pathway (K. Enesa and P. Cohen, unpublished work). However, the activation of the IKK-related kinases in the MyD88 pathway does not lead to the phosphorylation and activation of IRF3 or interferon β production, but instead plays an important role in limiting the extent of activation of the canonical IKKs [9, 20] . This may help to prevent the overproduction of inflammatory mediators that might otherwise lead to inflammatory and autoimmune diseases, as indicated by autoimmunity in mice that do not express TANK, a major binding partner for IKKε and TBK1 [21] . Once activated by the IKKrelated kinases, Pellino 1 may therefore also play a role in limiting the strength of MyD88 signalling by regulating another step of the pathway that has yet to be identified. Wild-type MEFs were incubated for 1 h without ( − ) or with ( + ) 2 μM MRT67307, without ( − ) or with ( + ) 1 μM 5-Z-7-oxozeanol, or with both compounds, before stimulation for 30 min with 5 ng/ml IL-1α. Pellino 1 was then immunoprecipitated from the extracts and assayed for ubiquitin ligase activity as described in the Experimental section of the main text. Similar results were obtained in a second independent experiment. p-, phospho.
